Epidermal growth factor receptor (EGFR) mutations exhibit varying prevalence across different ethnic groups and are present in approximately 17% of Caucasian and 39% of Asian patients with NSCLC, especially non-smokers. Here, EGFR is linked to non-small cell lung carcinoma.